Peptides is a category of molecules, so deregulating it and encouraging experimentation (or an ethos of 'sure whatever, try it') is astoundingly dangerous.
Scientific pharmaceutics is *entirely* about nailing down exactly what this or that substance does, not just, 'dunno, see what happens'.
Scientific pharmaceutics is *entirely* about nailing down exactly what this or that substance does, not just, 'dunno, see what happens'.
October 31, 2026 at 3:47 PM
Peptides is a category of molecules, so deregulating it and encouraging experimentation (or an ethos of 'sure whatever, try it') is astoundingly dangerous.
Scientific pharmaceutics is *entirely* about nailing down exactly what this or that substance does, not just, 'dunno, see what happens'.
Scientific pharmaceutics is *entirely* about nailing down exactly what this or that substance does, not just, 'dunno, see what happens'.
Comparative In Vitro Evaluation of #Buccal #Films, #Microcapsules, and #Liposomal Systems for Naringin and Citrus × paradisi L. Peel #Extract: Effects of #Encapsulation Strategy and #Compound Origin on #Release Profiles
Stabrauskiene et al.
www.mdpi.com/1999-4923/17...
#Pharmaceutics #OpenAccess
Stabrauskiene et al.
www.mdpi.com/1999-4923/17...
#Pharmaceutics #OpenAccess
November 2, 2026 at 9:55 AM
Comparative In Vitro Evaluation of #Buccal #Films, #Microcapsules, and #Liposomal Systems for Naringin and Citrus × paradisi L. Peel #Extract: Effects of #Encapsulation Strategy and #Compound Origin on #Release Profiles
Stabrauskiene et al.
www.mdpi.com/1999-4923/17...
#Pharmaceutics #OpenAccess
Stabrauskiene et al.
www.mdpi.com/1999-4923/17...
#Pharmaceutics #OpenAccess
📣 Exciting News: We are thrilled to welcome Dr. Magdalena Stevanović to the #Editorial #Board of #Pharmaceutics! 🚀
Dr. Stevanović is a Principal Research Fellow at ITS SASA, Serbia. Her research expertise includes:
➡️ Controlled #Drug #Delivery
➡️ #Nanomedicine
➡️ #Nanomaterials
#OpenAccess
Dr. Stevanović is a Principal Research Fellow at ITS SASA, Serbia. Her research expertise includes:
➡️ Controlled #Drug #Delivery
➡️ #Nanomedicine
➡️ #Nanomaterials
#OpenAccess
November 2, 2026 at 10:13 AM
📣 Exciting News: We are thrilled to welcome Dr. Magdalena Stevanović to the #Editorial #Board of #Pharmaceutics! 🚀
Dr. Stevanović is a Principal Research Fellow at ITS SASA, Serbia. Her research expertise includes:
➡️ Controlled #Drug #Delivery
➡️ #Nanomedicine
➡️ #Nanomaterials
#OpenAccess
Dr. Stevanović is a Principal Research Fellow at ITS SASA, Serbia. Her research expertise includes:
➡️ Controlled #Drug #Delivery
➡️ #Nanomedicine
➡️ #Nanomaterials
#OpenAccess
⭐ New Special Issue!
📚 Recent Advances in #Micro and #Nano #Drug #Delivery Systems🎯
🧑🔬 Dr. Elquio Eleamen Oliveira
🔔 Submission deadline: 31 May 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Nanoparticles #DrugDelivery #SpecialIssue #OpenAccess
📚 Recent Advances in #Micro and #Nano #Drug #Delivery Systems🎯
🧑🔬 Dr. Elquio Eleamen Oliveira
🔔 Submission deadline: 31 May 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Nanoparticles #DrugDelivery #SpecialIssue #OpenAccess
November 2, 2026 at 9:45 AM
⭐ New Special Issue!
📚 Recent Advances in #Micro and #Nano #Drug #Delivery Systems🎯
🧑🔬 Dr. Elquio Eleamen Oliveira
🔔 Submission deadline: 31 May 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Nanoparticles #DrugDelivery #SpecialIssue #OpenAccess
📚 Recent Advances in #Micro and #Nano #Drug #Delivery Systems🎯
🧑🔬 Dr. Elquio Eleamen Oliveira
🔔 Submission deadline: 31 May 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Nanoparticles #DrugDelivery #SpecialIssue #OpenAccess
🔥 Hot Off the Press!
📄 #Physiological #Barriers to #Nucleic #Acid #Therapeutics and Engineering Strategies for #Lipid #Nanoparticle #Design, #Optimization, and #Clinical Translation🚀
👩🔬 Kim et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #HotOffThePress #OpenAccess
📄 #Physiological #Barriers to #Nucleic #Acid #Therapeutics and Engineering Strategies for #Lipid #Nanoparticle #Design, #Optimization, and #Clinical Translation🚀
👩🔬 Kim et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #HotOffThePress #OpenAccess
October 29, 2026 at 9:52 AM
🔥 Hot Off the Press!
📄 #Physiological #Barriers to #Nucleic #Acid #Therapeutics and Engineering Strategies for #Lipid #Nanoparticle #Design, #Optimization, and #Clinical Translation🚀
👩🔬 Kim et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #HotOffThePress #OpenAccess
📄 #Physiological #Barriers to #Nucleic #Acid #Therapeutics and Engineering Strategies for #Lipid #Nanoparticle #Design, #Optimization, and #Clinical Translation🚀
👩🔬 Kim et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #HotOffThePress #OpenAccess
📣 Exciting News: We are thrilled to welcome Dr. Sean Avedissian to the Editorial Board of Pharmaceutics! 🎉
Dr. Avedissian is a Associate Professor at University of Florida, USA. His research expertise includes:
➡️ PK/PD
➡️ Pharmacometrics
➡️ Infectious Diseases
Dr. Avedissian is a Associate Professor at University of Florida, USA. His research expertise includes:
➡️ PK/PD
➡️ Pharmacometrics
➡️ Infectious Diseases
October 30, 2026 at 8:55 AM
📣 Exciting News: We are thrilled to welcome Dr. Sean Avedissian to the Editorial Board of Pharmaceutics! 🎉
Dr. Avedissian is a Associate Professor at University of Florida, USA. His research expertise includes:
➡️ PK/PD
➡️ Pharmacometrics
➡️ Infectious Diseases
Dr. Avedissian is a Associate Professor at University of Florida, USA. His research expertise includes:
➡️ PK/PD
➡️ Pharmacometrics
➡️ Infectious Diseases
🔥 Hot Off the Press!
📄 #Targeting #Glycolysis with 2-Deoxy-D-Glucose and #Lysosomal Integrity with L-Leucyl-L-Leucine Methyl Ester as #Antimelanoma Strategy❗
👩🔬 Kosic et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Melanoma #Glycolysis #HotOffThePress #OpenAccess
📄 #Targeting #Glycolysis with 2-Deoxy-D-Glucose and #Lysosomal Integrity with L-Leucyl-L-Leucine Methyl Ester as #Antimelanoma Strategy❗
👩🔬 Kosic et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Melanoma #Glycolysis #HotOffThePress #OpenAccess
October 29, 2026 at 9:55 AM
🔥 Hot Off the Press!
📄 #Targeting #Glycolysis with 2-Deoxy-D-Glucose and #Lysosomal Integrity with L-Leucyl-L-Leucine Methyl Ester as #Antimelanoma Strategy❗
👩🔬 Kosic et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Melanoma #Glycolysis #HotOffThePress #OpenAccess
📄 #Targeting #Glycolysis with 2-Deoxy-D-Glucose and #Lysosomal Integrity with L-Leucyl-L-Leucine Methyl Ester as #Antimelanoma Strategy❗
👩🔬 Kosic et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Melanoma #Glycolysis #HotOffThePress #OpenAccess
📢 #Deadline #Extended
The submission deadline for the #Special #Issue “Advances in #Pharmaceutics, #Genomics, and #Biotechnology for #Liver Disease #Therapy“ has been extended to 30 June 2027!
🔬 Guest Editor: Prof. Dr. Juan Socorro Armendariz-Borunda
🔗 www.mdpi.com/journal/phar...
The submission deadline for the #Special #Issue “Advances in #Pharmaceutics, #Genomics, and #Biotechnology for #Liver Disease #Therapy“ has been extended to 30 June 2027!
🔬 Guest Editor: Prof. Dr. Juan Socorro Armendariz-Borunda
🔗 www.mdpi.com/journal/phar...
October 29, 2026 at 9:48 AM
📢 #Deadline #Extended
The submission deadline for the #Special #Issue “Advances in #Pharmaceutics, #Genomics, and #Biotechnology for #Liver Disease #Therapy“ has been extended to 30 June 2027!
🔬 Guest Editor: Prof. Dr. Juan Socorro Armendariz-Borunda
🔗 www.mdpi.com/journal/phar...
The submission deadline for the #Special #Issue “Advances in #Pharmaceutics, #Genomics, and #Biotechnology for #Liver Disease #Therapy“ has been extended to 30 June 2027!
🔬 Guest Editor: Prof. Dr. Juan Socorro Armendariz-Borunda
🔗 www.mdpi.com/journal/phar...
Pharmacy Tutor Jobs
Explore exciting Pharmacy Tutor Jobs at TutorMitra. Teach subjects like Pharmacology, Pharmaceutics, and Medicinal Chemistry, share your expertise, guide students, and build a flexible and rewarding online teaching career.
Visit : www.tutormitra.com/pharmacy-tut...
Explore exciting Pharmacy Tutor Jobs at TutorMitra. Teach subjects like Pharmacology, Pharmaceutics, and Medicinal Chemistry, share your expertise, guide students, and build a flexible and rewarding online teaching career.
Visit : www.tutormitra.com/pharmacy-tut...
October 30, 2026 at 8:33 AM
Pharmacy Tutor Jobs
Explore exciting Pharmacy Tutor Jobs at TutorMitra. Teach subjects like Pharmacology, Pharmaceutics, and Medicinal Chemistry, share your expertise, guide students, and build a flexible and rewarding online teaching career.
Visit : www.tutormitra.com/pharmacy-tut...
Explore exciting Pharmacy Tutor Jobs at TutorMitra. Teach subjects like Pharmacology, Pharmaceutics, and Medicinal Chemistry, share your expertise, guide students, and build a flexible and rewarding online teaching career.
Visit : www.tutormitra.com/pharmacy-tut...
The authors included RRIDs in their in RSC Pharmaceutics paper! We value the author's support of reproducibility. #methodsmatter #ReproducibleResearch #OpenResearch
Mast cell agonism for glioblastoma immunotherapy
Read the full paper: Mast cell agonism for glioblastoma immunotherapy
doi.org
October 30, 2026 at 7:08 AM
The authors included RRIDs in their in RSC Pharmaceutics paper! We value the author's support of reproducibility. #methodsmatter #ReproducibleResearch #OpenResearch
⭐ New #Editor's #Choice Article!
📖 Could the timing between #pemetrexed and #osimertinib #administration be key to maximizing #treatment synergy in #EGFR-mutant non-small cell #lung #cancer?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Pemetrexed #Osimertinib #NSCLC #EditorsChoice
📖 Could the timing between #pemetrexed and #osimertinib #administration be key to maximizing #treatment synergy in #EGFR-mutant non-small cell #lung #cancer?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Pemetrexed #Osimertinib #NSCLC #EditorsChoice
October 30, 2026 at 10:10 AM
⭐ New #Editor's #Choice Article!
📖 Could the timing between #pemetrexed and #osimertinib #administration be key to maximizing #treatment synergy in #EGFR-mutant non-small cell #lung #cancer?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Pemetrexed #Osimertinib #NSCLC #EditorsChoice
📖 Could the timing between #pemetrexed and #osimertinib #administration be key to maximizing #treatment synergy in #EGFR-mutant non-small cell #lung #cancer?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Pemetrexed #Osimertinib #NSCLC #EditorsChoice
📢 Check out our new #TitleStory from Lopalco et al.
📜 #Stability Assessment of #Compounded Niaprazine #Oral #Solutions to Support an #Evidence-Based Beyond-Use Date 💊
🔗 Full text: mdpi.com/1999-4923/18/8/1006
#Pharmaceutics #Niaprazine #Oral #Formulation #OpenAccess
📜 #Stability Assessment of #Compounded Niaprazine #Oral #Solutions to Support an #Evidence-Based Beyond-Use Date 💊
🔗 Full text: mdpi.com/1999-4923/18/8/1006
#Pharmaceutics #Niaprazine #Oral #Formulation #OpenAccess
October 28, 2026 at 10:57 AM
📢 Check out our new #TitleStory from Lopalco et al.
📜 #Stability Assessment of #Compounded Niaprazine #Oral #Solutions to Support an #Evidence-Based Beyond-Use Date 💊
🔗 Full text: mdpi.com/1999-4923/18/8/1006
#Pharmaceutics #Niaprazine #Oral #Formulation #OpenAccess
📜 #Stability Assessment of #Compounded Niaprazine #Oral #Solutions to Support an #Evidence-Based Beyond-Use Date 💊
🔗 Full text: mdpi.com/1999-4923/18/8/1006
#Pharmaceutics #Niaprazine #Oral #Formulation #OpenAccess
🔥 Hot Off the Press!
📄The Potential of #Thymus zygis L. (Thyme) #Essential #Oil Coating in Preventing #Vulvovaginal #Candidiasis on Intrauterine Device (IUD) Strings🧫
👩🔬 Sahal et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Antifungal #Biofilm #HotOffThePress #OpenAccess
📄The Potential of #Thymus zygis L. (Thyme) #Essential #Oil Coating in Preventing #Vulvovaginal #Candidiasis on Intrauterine Device (IUD) Strings🧫
👩🔬 Sahal et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Antifungal #Biofilm #HotOffThePress #OpenAccess
October 28, 2026 at 9:11 AM
🔥 Hot Off the Press!
📄The Potential of #Thymus zygis L. (Thyme) #Essential #Oil Coating in Preventing #Vulvovaginal #Candidiasis on Intrauterine Device (IUD) Strings🧫
👩🔬 Sahal et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Antifungal #Biofilm #HotOffThePress #OpenAccess
📄The Potential of #Thymus zygis L. (Thyme) #Essential #Oil Coating in Preventing #Vulvovaginal #Candidiasis on Intrauterine Device (IUD) Strings🧫
👩🔬 Sahal et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Antifungal #Biofilm #HotOffThePress #OpenAccess
⭐ New #Editor's #Choice Article!
📖 Can microfluidic synthesis and SPAAC click chemistry improve the reproducibility, size control, and #drug-loading efficiency of poly(α-glutamic acid) #nanogels?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Microfluidic #Nanogels #SPAAC
·
📖 Can microfluidic synthesis and SPAAC click chemistry improve the reproducibility, size control, and #drug-loading efficiency of poly(α-glutamic acid) #nanogels?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Microfluidic #Nanogels #SPAAC
·
October 29, 2026 at 10:00 AM
⭐ New #Editor's #Choice Article!
📖 Can microfluidic synthesis and SPAAC click chemistry improve the reproducibility, size control, and #drug-loading efficiency of poly(α-glutamic acid) #nanogels?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Microfluidic #Nanogels #SPAAC
·
📖 Can microfluidic synthesis and SPAAC click chemistry improve the reproducibility, size control, and #drug-loading efficiency of poly(α-glutamic acid) #nanogels?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Microfluidic #Nanogels #SPAAC
·
⭐ New Editor's Choice Article!
📖 Can the novel N-degron-based #PROTAC NC1 overcome #chemoresistance in cervical #cancer by #targeting PLK1 for degradation and suppressing #tumor growth?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #CervicalCancer #PLK1 #PROTAC #EditorsChoice
📖 Can the novel N-degron-based #PROTAC NC1 overcome #chemoresistance in cervical #cancer by #targeting PLK1 for degradation and suppressing #tumor growth?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #CervicalCancer #PLK1 #PROTAC #EditorsChoice
October 29, 2026 at 10:01 AM
⭐ New Editor's Choice Article!
📖 Can the novel N-degron-based #PROTAC NC1 overcome #chemoresistance in cervical #cancer by #targeting PLK1 for degradation and suppressing #tumor growth?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #CervicalCancer #PLK1 #PROTAC #EditorsChoice
📖 Can the novel N-degron-based #PROTAC NC1 overcome #chemoresistance in cervical #cancer by #targeting PLK1 for degradation and suppressing #tumor growth?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #CervicalCancer #PLK1 #PROTAC #EditorsChoice
🔥 Hot Off the Press!
📄Application of #Biomimetic SPIONs in #Targeted #Lung #Cancer #Therapy: #Cell-Membrane Camouflage Technology and Lung Retention Enhancement Strategies🎯
👨🔬 Liu et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #SPIONs #LungCancer #HotOffThePress #OpenAccess
📄Application of #Biomimetic SPIONs in #Targeted #Lung #Cancer #Therapy: #Cell-Membrane Camouflage Technology and Lung Retention Enhancement Strategies🎯
👨🔬 Liu et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #SPIONs #LungCancer #HotOffThePress #OpenAccess
October 27, 2026 at 9:08 AM
🔥 Hot Off the Press!
📄Application of #Biomimetic SPIONs in #Targeted #Lung #Cancer #Therapy: #Cell-Membrane Camouflage Technology and Lung Retention Enhancement Strategies🎯
👨🔬 Liu et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #SPIONs #LungCancer #HotOffThePress #OpenAccess
📄Application of #Biomimetic SPIONs in #Targeted #Lung #Cancer #Therapy: #Cell-Membrane Camouflage Technology and Lung Retention Enhancement Strategies🎯
👨🔬 Liu et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #SPIONs #LungCancer #HotOffThePress #OpenAccess
🔥 #Hot Off the Press!
📄Boronic #Derivatives of #Thiosemicarbazones as #Tyrosinase #Inhibitors🚀
👨🔬 Jewgiński et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #TyrosinaseInhibitors #MolecularDocking #StructureActivityRelationships #HotOffThePress #OpenAccess
📄Boronic #Derivatives of #Thiosemicarbazones as #Tyrosinase #Inhibitors🚀
👨🔬 Jewgiński et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #TyrosinaseInhibitors #MolecularDocking #StructureActivityRelationships #HotOffThePress #OpenAccess
October 26, 2026 at 10:35 AM
🔥 #Hot Off the Press!
📄Boronic #Derivatives of #Thiosemicarbazones as #Tyrosinase #Inhibitors🚀
👨🔬 Jewgiński et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #TyrosinaseInhibitors #MolecularDocking #StructureActivityRelationships #HotOffThePress #OpenAccess
📄Boronic #Derivatives of #Thiosemicarbazones as #Tyrosinase #Inhibitors🚀
👨🔬 Jewgiński et al.
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #TyrosinaseInhibitors #MolecularDocking #StructureActivityRelationships #HotOffThePress #OpenAccess
Discover how Yue Lu, PhD, a molecular pharmaceutics researcher at University of Utah Health, is pioneering innovative technologies aimed at preventing disease and enabling personalized treatment strategies. https://youtu.be/7FuJ2_GwgZY?si=6T9ETu-Hn35ERWnS
October 26, 2026 at 1:19 PM
Discover how Yue Lu, PhD, a molecular pharmaceutics researcher at University of Utah Health, is pioneering innovative technologies aimed at preventing disease and enabling personalized treatment strategies. https://youtu.be/7FuJ2_GwgZY?si=6T9ETu-Hn35ERWnS
⭐ New #Editor's #Choice #Article!
📖 Can folic #acid-modified #PLGA #nanoparticles enhance the #targeted #delivery of fluoxetine to #glioblastoma cells and overcome the limitations of conventional #therapies?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Glioblastoma #Fluoxetine #PGLA
📖 Can folic #acid-modified #PLGA #nanoparticles enhance the #targeted #delivery of fluoxetine to #glioblastoma cells and overcome the limitations of conventional #therapies?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Glioblastoma #Fluoxetine #PGLA
October 28, 2026 at 10:55 AM
⭐ New #Editor's #Choice #Article!
📖 Can folic #acid-modified #PLGA #nanoparticles enhance the #targeted #delivery of fluoxetine to #glioblastoma cells and overcome the limitations of conventional #therapies?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Glioblastoma #Fluoxetine #PGLA
📖 Can folic #acid-modified #PLGA #nanoparticles enhance the #targeted #delivery of fluoxetine to #glioblastoma cells and overcome the limitations of conventional #therapies?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #Glioblastoma #Fluoxetine #PGLA
⭐ New #Editor's #Choice #Article!
📖 How can #anti-PEG #antibodies affect the safety and efficacy of #PEGylated #therapeutics, and what strategies could help reduce PEG-related #immune responses?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #AntiPEG #Biocompatibility #Immunogenicity
📖 How can #anti-PEG #antibodies affect the safety and efficacy of #PEGylated #therapeutics, and what strategies could help reduce PEG-related #immune responses?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #AntiPEG #Biocompatibility #Immunogenicity
October 28, 2026 at 9:20 AM
⭐ New #Editor's #Choice #Article!
📖 How can #anti-PEG #antibodies affect the safety and efficacy of #PEGylated #therapeutics, and what strategies could help reduce PEG-related #immune responses?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #AntiPEG #Biocompatibility #Immunogenicity
📖 How can #anti-PEG #antibodies affect the safety and efficacy of #PEGylated #therapeutics, and what strategies could help reduce PEG-related #immune responses?
🔗 www.mdpi.com/1999-4923/17...
#Pharmaceutics #AntiPEG #Biocompatibility #Immunogenicity
📢 Deadline Extended
🖊️ #Special #Issue: “Bioactive #Phytochemicals from Medicinal Plants: #Formulation and Therapeutic Potential” 💊
⏰ 30 June 2027
🔬 Guest Editors: Dr. Ademar Alves Da Silva Filho and Dr. Radhia Aitfella Lahlou
🔗https://www.mdpi.com/journal/pharmaceutics/special_issues/FJ63W0P2S3
🖊️ #Special #Issue: “Bioactive #Phytochemicals from Medicinal Plants: #Formulation and Therapeutic Potential” 💊
⏰ 30 June 2027
🔬 Guest Editors: Dr. Ademar Alves Da Silva Filho and Dr. Radhia Aitfella Lahlou
🔗https://www.mdpi.com/journal/pharmaceutics/special_issues/FJ63W0P2S3
October 28, 2026 at 9:02 AM
📢 Deadline Extended
🖊️ #Special #Issue: “Bioactive #Phytochemicals from Medicinal Plants: #Formulation and Therapeutic Potential” 💊
⏰ 30 June 2027
🔬 Guest Editors: Dr. Ademar Alves Da Silva Filho and Dr. Radhia Aitfella Lahlou
🔗https://www.mdpi.com/journal/pharmaceutics/special_issues/FJ63W0P2S3
🖊️ #Special #Issue: “Bioactive #Phytochemicals from Medicinal Plants: #Formulation and Therapeutic Potential” 💊
⏰ 30 June 2027
🔬 Guest Editors: Dr. Ademar Alves Da Silva Filho and Dr. Radhia Aitfella Lahlou
🔗https://www.mdpi.com/journal/pharmaceutics/special_issues/FJ63W0P2S3
🎉 #Pharmaceutics Exceptional #Reviewers List 2026 (Q3) is announced!
Congratulations to all the exceptional reviewers recognized in Q3 2026. We sincerely thank you for your valuable time, expertise, and continued support for Pharmaceutics.
🔗 www.mdpi.com/journal/phar...
Congratulations to all the exceptional reviewers recognized in Q3 2026. We sincerely thank you for your valuable time, expertise, and continued support for Pharmaceutics.
🔗 www.mdpi.com/journal/phar...
October 26, 2026 at 10:44 AM
🎉 #Pharmaceutics Exceptional #Reviewers List 2026 (Q3) is announced!
Congratulations to all the exceptional reviewers recognized in Q3 2026. We sincerely thank you for your valuable time, expertise, and continued support for Pharmaceutics.
🔗 www.mdpi.com/journal/phar...
Congratulations to all the exceptional reviewers recognized in Q3 2026. We sincerely thank you for your valuable time, expertise, and continued support for Pharmaceutics.
🔗 www.mdpi.com/journal/phar...
📢 Deadline Extended – #Special #Issue
The submission deadline for the Special Issue “ #Ocular #Drug #Delivery and Tissue #Repair Strategies” has been extended to 30 June 2027! 💊
🔬: Dr. Surajit Dey and Dr. Remya Ammassam Veettil
🔗https://www.mdpi.com/journal/pharmaceutics/special_issues/3EF1R86ZNU
The submission deadline for the Special Issue “ #Ocular #Drug #Delivery and Tissue #Repair Strategies” has been extended to 30 June 2027! 💊
🔬: Dr. Surajit Dey and Dr. Remya Ammassam Veettil
🔗https://www.mdpi.com/journal/pharmaceutics/special_issues/3EF1R86ZNU
October 27, 2026 at 9:06 AM
📢 Deadline Extended—30 June 2027!
"Pharmacokinetic Perspectives on #Drug #Interactions in Therapy" 💊
🔬 Prof. Dr. Kaloyan Georgiev & Dr. Nicola Gambacorta
🔗 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Pharmacokinetics
"Pharmacokinetic Perspectives on #Drug #Interactions in Therapy" 💊
🔬 Prof. Dr. Kaloyan Georgiev & Dr. Nicola Gambacorta
🔗 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Pharmacokinetics
October 26, 2026 at 10:31 AM
📢 Deadline Extended—30 June 2027!
"Pharmacokinetic Perspectives on #Drug #Interactions in Therapy" 💊
🔬 Prof. Dr. Kaloyan Georgiev & Dr. Nicola Gambacorta
🔗 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Pharmacokinetics
"Pharmacokinetic Perspectives on #Drug #Interactions in Therapy" 💊
🔬 Prof. Dr. Kaloyan Georgiev & Dr. Nicola Gambacorta
🔗 Full details and submission link: www.mdpi.com/journal/phar...
#Pharmaceutics #Pharmacokinetics
⭐ New #Special #Issue! - #Pharmaceutics
📚Therapeutic #Biomaterials for #Drug #Delivery and #Regenerative Medicine
🧑🔬 Dr. Cecília de Barros and Dr. Thaís Francine Ribeiro Alves
🔔 Submission deadline: 30 April 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
📚Therapeutic #Biomaterials for #Drug #Delivery and #Regenerative Medicine
🧑🔬 Dr. Cecília de Barros and Dr. Thaís Francine Ribeiro Alves
🔔 Submission deadline: 30 April 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
October 26, 2026 at 10:28 AM
⭐ New #Special #Issue! - #Pharmaceutics
📚Therapeutic #Biomaterials for #Drug #Delivery and #Regenerative Medicine
🧑🔬 Dr. Cecília de Barros and Dr. Thaís Francine Ribeiro Alves
🔔 Submission deadline: 30 April 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...
📚Therapeutic #Biomaterials for #Drug #Delivery and #Regenerative Medicine
🧑🔬 Dr. Cecília de Barros and Dr. Thaís Francine Ribeiro Alves
🔔 Submission deadline: 30 April 2027
👉 Full details and submission link: www.mdpi.com/journal/phar...